Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy

  • El Awady M
  • Anany M
  • Esmat G
 et al. 
  • 25


    Mendeley users who have this article in their library.
  • 20


    Citations of this article.


Response to interferon therapy and disease progression in hepatitis C virus (HCV) infected patients differs among individuals, suggesting a possibility of a contribution of host genetic factors. 2'-5'-oligoadenylate synthetase 1 (OAS1), an important component of the innate immune system with a proven antiviral function, may therefore have a relationship with the response to interferon therapy and clinical course of HCV disease. Our aim was to determine the frequency of single nucleotide polymorphism (SNP) at exon 7 splice acceptor site (SAS) of the OAS1 gene in relation to the interferon response and status of HCV infection.

Author-supplied keywords

  • Hepatitis C virus
  • Liver fibrosis
  • OAS1
  • Response to interferon therapy
  • Single nucleotide polymorphism

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • Mostafa K. El Awady

  • Mohamed A. Anany

  • Gamal Esmat

  • Naglaa Zayed

  • Ashraf A. Tabll

  • Amr Helmy

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free